Depression Market Intelligence Review and Insights Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Depression: Market Intelligence Review and Insights" report has been added to ResearchAndMarkets.com's offering.

Depression: Market Intelligence Review and Insights report delivers an in-depth understanding of the disease, and cover in detail the major research events, competitor events, physicians and patients findings updates in a month and their potential implications on the Market and the Pharmaceutical firms researching or marketing their drugs in the disease area.

Key Topics Covered:

1 Tables & Figures

2 Executive Summary

3 Disease Overview

3.1 Disease Definition

3.2 Disease Etiology and Pathophysiology

3.2.1 Etiology

3.2.2 Pathophysiology

3.2.3 Impact on Quality of Life

3.3 Symptoms of the Disease

3.4 Disease Diagnosis

3.5 Treatment Guidelines

3.6 Key unmet needs

4 Market Intelligence Information Overview and Potential Implications

4.1 Countries Covered

4.1.1 France

4.1.2 Germany

4.1.3 Italy

4.1.4 Spain

4.1.5 United Kingdom

4.1.6 United States

4.1.7 Japan

5 Appendix

Companies Mentioned

  • Eisai
  • Sumitomo Dainippon Pharma
  • Sepracor
  • WhanIn Pharmaceutical
  • BIAL
  • moksha8 Pharmaceuticals
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Aptalis Holdings
  • Eurand
  • Aspen Pharmacare
  • Faes Farma
  • Adare Pharmaceuticals
  • AbbVie
  • Abbott Laboratories
  • Sanofi
  • SciClone Pharmaceuticals
  • NovaMed Pharmaceuticals
  • Otsuka Holdings
  • Esteve
  • Hikma Pharmaceuticals
  • Megapharm
  • Grupo Biotoscana
  • Alfresa Holdings
  • ORPHELIA Pharma
  • Daewoong Pharmaceutical
  • Supernus Pharmaceuticals
  • Aequus Pharmaceuticals
  • GW Pharmaceuticals
  • Takeda
  • Ovid Therapeutics
  • Zogenix
  • Ligand Pharmaceuticals
  • Purdue Pharma
  • Marinus Pharmaceuticals
  • Zynerba Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/74dtjs/depression?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs